THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Kenichi Tanaka to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Kenichi Tanaka has written about Antibodies, Monoclonal, Humanized.
Kenichi Tanaka
Connection Strength
0.836
Antibodies, Monoclonal, Humanized
  1. Idarucizumab for Dabigatran Reversal in Emergency Type-A Aortic Dissection. J Cardiothorac Vasc Anesth. 2017 12; 31(6):e80-e81.
    View in: PubMed
    Score: 0.495
  2. In vitro effects of emicizumab on activated clotting time in blood samples from cardiac surgical patients. Haemophilia. 2022 Jan; 28(1):183-190.
    View in: PubMed
    Score: 0.181
  3. Whole Blood Point-of-Care Testing for Incomplete Reversal With Idarucizumab in Supratherapeutic Dabigatran. Anesth Analg. 2020 02; 130(2):535-541.
    View in: PubMed
    Score: 0.160
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES